Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Forte Biosciences Inc (NQ: FBRX )

0.6401 -0.0399 (-5.87%)
Streaming Delayed Price Updated: 3:05 PM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Forte Biosciences Inc

< Previous 1 2 3 Next >
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Exposures COVID-19
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
Unusual Options Activity Insight: Forte Biosciences
On Friday, shares of Forte Biosciences (NASDAQ:FBRX) saw u... 
Via Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff... 
Via Benzinga
21 Stocks Moving in Thursday's Pre-Market Session
Gainers Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (... 
Via Benzinga
53 Biggest Movers From Friday
Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera... 
Via Benzinga
5 Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday... 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down 1%; MongoDB Shares Jump After Q2 Results
Toward the end of trading Friday, the Dow traded down 0.11% to 35,403.67 while the NASDAQ rose 0.23% to 15,366.71. The S&P also rose, gaining 0.04% to 4,538.92. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Forte Biosciences Stock Is Down Over 80% Today
Forte Biosciences (NASDAQ: FBRX) is tanking today after the company announced the clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
Dow Steps Back, Nasdaq Reaches For More Records
The Dow Jones Industrial Index is taking a breather today, last seen down 56 points, after August's jobs report came in much lower than expected. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge
Midway through trading Friday, the Dow traded down 0.23% to 35,361.40 while the NASDAQ rose 0.02% to 15,333.95. The S&P also fell, dropping 0.22% to 4,527.17. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
35 Stocks Moving In Friday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a... 
Via Benzinga
Why Forte Biosciences Stock Is Imploding Today
The company announced dismal results from a phase 2 study of its only pipeline candidate. 
Via The Motley Fool
Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August
Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66. The U.S.... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million.... 
Via Benzinga
20 Stocks Moving in Friday's Pre-Market Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Rise; All Eyes On Jobs Report
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the release of jobs report for August. Analysts expect nonfarm payrolls rising 740,000 for... 
Via Benzinga
Forte Biosciences Just Plummeted 80%: Here's Why
A biopharmaceutical company focused on the development of dermatology treatments saw a sharp drop after hours Thursday. What Happened: The clinical trial of Forte Biosciences (... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Protagenic Therapeutics (NASDAQ:PTIX... 
Via Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374... 
Via Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday. LM Funding America, Inc. (NASDAQ: LMFA) rose... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Strata Skin Sciences (NASDAQ:SSKN 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.